Hinge Health (HNGE) EPS (Weighted Average and Diluted) (2024 - 2026)

Hinge Health has disclosed EPS (Weighted Average and Diluted) across 3 years of filings, most recently posting $0.41 for Q1 2026.

• EPS (Weighted Average and Diluted) for Q1 2026 came in at $0.41, down 68.7% year-over-year; the trailing twelve-month figure through Mar 2026 was -$10.6 (down 547.26% YoY), and the FY2025 annual result was -$7.77, down 782.95% from the prior year.
• EPS (Weighted Average and Diluted) came in at $0.41 for Q1 2026 at Hinge Health, down from $2.11 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $2.11 in Q4 2025 to a low of -$13.1 in Q2 2025.
• The 3-year median for EPS (Weighted Average and Diluted) is $0.21 (2024), against an average of -$1.03.
• Peak annual rise in EPS (Weighted Average and Diluted) reached 4.98% in 2025, while the deepest fall reached 1264.58% in 2025.
• Hinge Health's EPS (Weighted Average and Diluted) stood at $2.01 in 2024, then grew by 4.98% to $2.11 in 2025, then slumped by 80.57% to $0.41 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at $0.41 (Q1 2026), $2.11 (Q4 2025), and -$0.02 (Q3 2025), per Business Quant data.